{"entity":{"id":"nct04891198","kind":"trial","name":"ENVAFOLIMAB Single-agent Treatment in Patients With Advanced Solid Tumors","aka":[],"tldr":"A phase 2 trial of Envafolimab in advanced solid tumours, run by 3D Medicines (Sichuan) Co., Ltd., now recruiting.","summary":"ENVAFOLIMAB Single-agent Treatment in Patients With Advanced Solid Tumors is a phase 2 interventional study registered as NCT04891198 by 3D Medicines (Sichuan) Co., Ltd., with 126 participants planned, started 2021-08-06 and due to reach its primary completion in 2027-08-30. Interventions recorded: Envafolimab.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT04891198","url":"https://clinicaltrials.gov/study/NCT04891198"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":["checkpoint-inhibitor","monoclonal-antibody"],"targets":[],"drugs":["envafolimab"],"companies":["3d-medicines"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT04891198","phase":"2","setting":"An Open, Single-arm, Multi-center Phase II Clinical Study of ENVAFOLIMAB Single-agent Treatment in Patients With Advanced Solid Tumors","sponsor":"3D Medicines (Sichuan) Co., Ltd.","participation":[{"nct":"NCT04891198","source":"https://clinicaltrials.gov/study/NCT04891198","fetchedAt":"2026-10-07T16:53:30.019Z","studySha256":"35eaaf1c7a6749cbaea3bef4b2d25f1840e925e14237335b786560ab0ee47114","overallStatus":"RECRUITING","lastUpdatePosted":"2026-03-25","leadSponsor":"3D Medicines (Sichuan) Co., Ltd.","collaboratorCount":0,"minimumAge":"18 Years","sex":"ALL","healthyVolunteers":false,"hasEligibility":true,"enrolment":126,"enrolmentType":"ESTIMATED","siteCount":1,"recruitingSiteCount":1,"countries":["China"]}],"started":"2021-08-06","startedType":"actual","enrolled":126,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct04891198/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}],"technology":[{"id":"checkpoint-inhibitor","kind":"technology","name":"Immune checkpoint inhibitors","route":"/technologies/checkpoint-inhibitor/"},{"id":"monoclonal-antibody","kind":"technology","name":"Monoclonal antibodies","route":"/technologies/monoclonal-antibody/"}],"drug":[{"id":"envafolimab","kind":"drug","name":"Envafolimab","route":"/drugs/envafolimab/"}],"company":[{"id":"3d-medicines","kind":"company","name":"3D Medicines","route":"/companies/3d-medicines/"}]}}